引用本文
  • 沈睿,舒仲文,陈刘炜.双重抗血小板聚集治疗对动脉瘤性蛛网膜下腔出血的疗效评估[J].同济大学学报(医学版),2023,44(1):32-40.    [点击复制]
  • SHEN Rui,SHU Zhongwen,CHEN Liuwei.Efficacy evaluation of dual antiplatelet therapy in patients with aneurysmal subarachnoid hemorrhage[J].Journal of Tongji University(Medical Science),2023,44(1):32-40.   [点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 286次   下载 365 本文二维码信息
码上扫一扫!
双重抗血小板聚集治疗对动脉瘤性蛛网膜下腔出血的疗效评估
沈睿,舒仲文,陈刘炜
0
(同济大学附属第十人民医院神经外科,上海200072)
摘要:
目的探究双重抗血小板聚集(双抗)治疗对动脉瘤性蛛网膜下腔出血(aneurysmal subarachnoid hemorrhage, aSAH)患者迟发性脑缺血(delayed cerebral ischemia, DCI)的影响及疗效评估。方法回顾性地收集并分析了2019年1月—2021年12月在同济大学附属第十人民医院神经外科接受破裂动脉瘤介入栓塞治疗的186例aSAH患者的临床资料。根据有无使用双抗将患者分成双抗组和对照组,比较两组间DCI发生率、急性脑积水发生率、脑室外引流置管率、出血性并发症发生率、3个月功能预后的差异。结果186例aSAH患者中,有64例患者接受了支架辅助栓塞,接受了双抗治疗进而分为双抗组;有122例患者接受了单纯栓塞或球囊辅助栓塞,没有接受抗血小板聚集治疗,进而分为对照组。双抗组的DCI发生率低于对照组(14.1% vs 27.0%,P=0.044)。双抗组和对照组急性脑积水发生率(10.9% vs 10.7%, P=0.953)、脑室外引流置管率(4.7% vs 6.6%, P=0.608)、出血性并发症发生率(3.1% vs 0.8%, P=0.236)、3个月功能预后(mRS评分≤2分,90.6% vs 86.1%, P=0.370)差异无统计学意义。结论在接受了血管内治疗的aSAH患者中,使用双抗治疗能够降低DCI的发生率,且不会增加出血性并发症发生率,具有一定的临床应用前景。
关键词:  迟发性脑缺血  蛛网膜下腔出血  抗血小板治疗  颅内动脉瘤
DOI:10.12289/j.issn.1008-0392.22188
通信作者:
投稿时间:2022-05-05
录用日期:
基金项目:
Efficacy evaluation of dual antiplatelet therapy in patients with aneurysmal subarachnoid hemorrhage
SHEN Rui,SHU Zhongwen,CHEN Liuwei
(Department of Neurosurgery, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai 200072, China)
Abstract:
ObjectiveTo evaluate the efficacy of dual antiplatelet therapy(DAPT) in patients with aneurysmal subarachnoid hemorrhage(aSAH). MethodsClinical data of 186 aSAH patients who received endovascular treatment in Shanghai Tenth People’s Hospital between January 2019 and December 2021 were retrospectively analyzed. Patients were divided into two groups: patients who underwent stent-assisted coiling requiring DAPT(n=64, DAPT group) and patients who underwent coiling only or balloon-assisted coiling without DAPT(n=122, control group). The risk of delayed cerebral ischemia(DCI) , acute hydrocephalus, placement of an external ventricular drain(EVD), hemorrhagic complications, and 3-month functional outcome were compared between the two groups. ResultsThe risk of DCI in DAPT group was significantly lower than that in control group (14.1% vs 27.0%, P=0.044). There were no significant differences in acute hydrocephalus, EVD placement, hemorrhagic complications, and 3-month functional outcomes between the groups(all P>0.05). ConclusionThe use of DAPT is associated with a lower risk of DCI in aSAH patients following endovascular treatment.
Key words:  delayed cerebral ischemia  subarachnoid hemorrhage  antiplatelet therapy  intracranial aneurysm

您是第6218344位访问者
网站版权 © 《同济大学学报(医学版)》编辑部
主管单位:教育部 主办单位:同济大学
地  址: 上海四平路1239号 邮编:200092 电话:021-65980705 E-mail: yxxb@tongji.edu.cn
本系统由北京勤云科技发展有限公司设计